Commentary : A perspective of traditional Chinese medicine, curcumin, for the treatment of COVID-19

Siukan LAW*, Chuiman LO, Jie HAN, Albert Wingnang LEUNG, Chuanshan XU

*Corresponding author for this work

Research output: Journal PublicationsComment / Debate Communicationpeer-review

Abstract

Curcuma longa (curcumin) is a traditional Chinese herbal medicine that has been used in many traditional medicine systems for a long time because of its wide range of pharmacological properties and applications. Based on the traditional Chinese medicine theory, curcumin belongs to the ‘invigorate blood’ category and COVID-19 belongs to the ‘epidemic’ category. Curcumin is one of the possible candidates that could be used in the treatment of COVID-19 as it possesses anti-inflammatory and antiviral properties according to previous studies. The Chinese medicine formulation that includes curcumin, ‘Qingfei Touxie Fuzheng decoction’, was developed with this in mind. In this article, the mechanisms of C. longa L for COVID-19 will be discussed.
Original languageEnglish
Pages (from-to)165-166
Number of pages2
JournalAustralian Journal of Herbal and Naturopathic Medicine
Volume32
Issue number4
Publication statusPublished - Dec 2020

Keywords

  • traditional Chinese medicine
  • curcumin
  • COVID-19

Fingerprint Dive into the research topics of 'Commentary : A perspective of traditional Chinese medicine, curcumin, for the treatment of COVID-19'. Together they form a unique fingerprint.

Cite this